Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Bolen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Opioid Management|February 24, 2007
Taking back your turf: understanding the role of law in medical decision making in opioid management (Part II--putting legal/regulatory materials to work for you)Jennifer Bolen
Journal of Pain & Palliative Care Pharmacotherapy|December 8, 2010
Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic painDavid B Brushwood, Ben A Rich, John J Coleman, et al.
Journal of Mammary Gland Biology and Neoplasia|February 16, 2021
Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex ImmunofluorescenceHidetoshi Mori, Jennifer Bolen, Louis Schuetter, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cell Reports. Medicine|November 7, 2024
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancerMichael J Campbell, Denise M Wolf, Christina Yau, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Opioid Management|February 24, 2007
Taking back your turf: understanding the role of law in medical decision making in opioid management (Part II--putting legal/regulatory materials to work for you)Jennifer Bolen
Journal of Pain & Palliative Care Pharmacotherapy|December 8, 2010
Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic painDavid B Brushwood, Ben A Rich, John J Coleman, et al.
Journal of Mammary Gland Biology and Neoplasia|February 16, 2021
Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex ImmunofluorescenceHidetoshi Mori, Jennifer Bolen, Louis Schuetter, et al.
JCI Insight|September 21, 2021
Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancerMehdi Bouhaddou, Rex H Lee, Hua Li, et al.
Cell Reports. Medicine|November 7, 2024
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancerMichael J Campbell, Denise M Wolf, Christina Yau, et al.
Pageof 1